DrugPatentWatch Database Preview
Watson Labs Company Profile
» See Plans and Pricing
What is the competitive landscape for WATSON LABS, and what generic and branded alternatives to WATSON LABS drugs are available?
WATSON LABS has one thousand and thirty-five approved drugs.
There are nineteen tentative approvals on WATSON LABS drugs.
Summary for Watson Labs
| US Patents: | 0 |
| Tradenames: | 399 |
| Ingredients: | 376 |
| NDAs: | 1035 |
Drugs and US Patents for Watson Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | HYDROXYZINE HYDROCHLORIDE | hydroxyzine hydrochloride | TABLET;ORAL | 081151-001 | Mar 18, 1994 | DISCN | No | No | Start Trial | Start Trial | |||||
| Watson Labs | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | TABLET;ORAL | 074864-001 | Oct 20, 1997 | DISCN | No | No | Start Trial | Start Trial | |||||
| Watson Labs | METHYLPREDNISOLONE SODIUM SUCCINATE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 088523-001 | Jul 24, 1984 | DISCN | No | No | Start Trial | Start Trial | |||||
| Watson Labs | PROCAINAMIDE HYDROCHLORIDE | procainamide hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 089520-001 | Jan 15, 1987 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
